Physician

Zonera Ashraf Ali, MD

According to 2025 Medicare claims, Zonera Ali, MD (NPI: 1306852728) practices hematology/oncology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is ALLIANCE CANCER SPECIALISTS P.C. (NPI: 1487923686; TIN: 452552343) and primary practice location at 19096-3450.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 541 traditional Medicare patients, billed 141,292 HCPCS/CPT codes, and received $2,615,375 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,396 prescription claims across 238 beneficiaries totaling $3,347,401 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 91 claims. Open Payments data shows 145 records totaling $3,431. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,436,277 to $2,615,375. Similarly, Part D prescription costs have risen steadily, from $1,124,211 to $3,347,401. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	419	94,324	$1,436,277
2016	460	151,361	$1,952,442
2017	427	129,082	$2,045,850
2018	439	95,681	$1,742,363
2019	524	106,469	$1,853,733
2020	488	113,162	$1,849,799
2021	514	166,609	$1,927,462
2022	573	149,572	$2,508,012
2023	553	144,630	$2,048,837
2024	541	141,292	$2,615,375

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	159	1,080	$1,124,211
2016	163	1,363	$1,687,580
2017	165	1,304	$2,058,297
2018	159	1,325	$2,460,844
2019	208	1,411	$2,799,120
2020	228	1,555	$2,594,768
2021	239	1,386	$2,308,010
2022	235	1,398	$3,248,928
2023	221	1,295	$2,544,701
2024	238	1,396	$3,347,401

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	124	$5,181
2016	N/R	138	$5,056
2017	N/R	138	$5,600
2018	N/R	N/R	N/R
2019	N/R	57	$5,999
2020	N/R	84	$9,120
2021	N/R	36	$756
2022	N/R	66	$1,409
2023	N/R	69	$1,714
2024	N/R	91	$4,840

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	48	48	$191
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	59	64	$151
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	251	616	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	251	318	$76
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	384	602	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	57	1,519	$705,275
Calquence	Acalabrutinib Maleate	24	720	$347,073
Ibrance	Palbociclib	17	448	$270,281
Jakafi	Ruxolitinib Phosphate	13	390	$245,728
Lorbrena	Lorlatinib	11	330	$232,463

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	12	$2,465
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	22	$800
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$637
J9190	Injection, fluorouracil, 500 mg	N	N/R	22	$516
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	22	$422

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	145	$3,431	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Zonera Ashraf Ali, MD?

Tedicare shows public-source Medicare data for Zonera Ashraf Ali, MD (NPI 1306852728), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zonera Ashraf Ali, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Zonera Ashraf Ali, MD?

Zonera Ashraf Ali, MD is linked to ALLIANCE CANCER SPECIALISTS P.C. (billing NPI 1487923686) in the available physician profile data.

Does Zonera Ashraf Ali, MD have Open Payments data?

Zonera Ashraf Ali, MD has 145 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.